Category: Uncategorized

Pharmacovigilance Quality Assurance & Compliance Auditing

Pharmacovigilance Quality Assurance & Compliance Auditing

A Top 10 Global Biopharmaceutical Company faced increasing regulatory scrutiny and needed to strengthen its Pharmacovigilance (PV) quality systems worldwide. The project included 15+ global PV audits across 9 months, addressing inconsistent PV practices across

Read More
Accelerated Global Safety Database Implementation

Accelerated Global Safety Database Implementation​

A mid-sized U.S.-based pharmaceutical company approached Vigilare to rapidly implement a global safety database within an aggressive four-week timeline. The scope involved migrating 4,000+ legacy safety cases (some over 20 years old), supporting 4 affiliate

Read More
The-Importance-of-Vendor-Audits-Ensuring-Compliance-and-Quality-Across-Industries

The Importance of Vendor Audits: Ensuring Compliance and Quality Across Industries

The Importance of Vendor Audits: Ensuring Compliance and Quality Across Industries In today’s complex business environment, vendor audits play a critical role in maintaining quality, regulatory compliance, and operational integrity. Whether in healthcare, manufacturing, technology,

Read More
Vigilare-Biopharma-Insights-TGA-Seeks-Feedback-to-Modernize-Clinical-Trial-Pharmacovigilance-Standards

Vigilare Biopharma Insights: TGA Seeks Feedback to Modernize Clinical Trial & Pharmacovigilance Standards

TGA Seeks Feedback to Modernize Clinical Trial & Pharmacovigilance Australia’s Therapeutic Goods Administration (TGA) is revising its clinical trial and pharmacovigilance guidelines to align with global benchmarks—a move poised to reshape research and drug safety practices.

Read More
Embracing Diversity, Equity & Inclusion (DEI) in Clinical Research: A New Era in Healthcare Innovation

Advancing Diversity, Equity, and Inclusion (DEI) in Clinical Research: A Path Toward Equitable Healthcare

As clinical research advances in complexity and innovation, the urgency for diversity, equity, and inclusion (DEI) in trials has never been more critical. Beyond regulatory compliance or industry buzzwords, DEI in clinical trials is about

Read More

The Future of Pharma Regulatory Affairs: Trends to Watch in 2025

The Future of Pharma Regulatory Affairs The pharmaceutical regulatory landscape is undergoing significant transformation, driven by the need to keep pace with technological advances, global collaboration, and an increased focus on patient safety. As we

Read More
How Vigilare Biopharma Helps You Get Your Medical Devices Approved by the FDA

Get Your Medical Devices Approved by the FDA

How Vigilare Biopharma Helps You Get Your Medical Devices Approved by the FDA Navigating the complex landscape of FDA approval for medical devices can be daunting. At Vigilare Biopharma, we specialize in guiding companies through

Read More
FDA Approves First Oral Treatment for Postpartum Depression

FDA Approves Zurzuvae: First Oral Medication for Postpartum Depression (PPD)

The U.S. Food and Drug Administration (FDA) has given its stamp of approval to Zurzuvae (zuranolone), marking it as the first oral medication specifically designed to treat postpartum depression (PPD) in adults. PPD is a

Read More

Case Study of a manufacturer focused on Branded Formulations, Specialty Generic Injectables, Synthetic Biology, Vaccines and Biologics

Case Study An India based manufacturer, focused on Branded Formulations, Specialty Generic Injectables, Synthetic Biology, Vaccines and Biologics At A Glance Challenges Medical Inquiries Product Complaints Adverse Drug Experience Reporting Other Categories Combination of the

Read More